Phase I trial: Fortrea code: 8476207

Phase 1

Completed

• Conditions: Not Applicable; Healthy volunteers

• Registration Number: ISRCTN88307799
• Lead Sponsor: Vifor (International) Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-12-15
• Study Start: 2023-10-18
• Last Update Posted: 4 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.

Exclusion Criteria

The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.

Secondary Outcome Measures

Name	Time	Method
The HRA has approved deferral of publication of trial details. The full details will be added to the study record within 30 months after the trial has ended.